Personalised therapeutic management of epileptic patients guided by pathway-driven breath metabolomics.

Kapil Dev SinghMartin OsswaldVictoria C ZiesenitzMo AwchiJakob UsemannLukas L ImbachMalcolm KohlerDiego García-GómezJohannes van den AnkerUrs FreyAlexandre N DattaPablo M-L Sinues

Published in: Communications medicine (2021)

These results show that real-time breath analysis of epileptic patients provides reliable estimations of systemic drug concentrations along with risk estimates for drug response and side effects.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
mass spectrometry
emergency department
drug induced